Stocks
Denali Therapeutics (DNLI) P/FCF US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| P/FCF | -24.6 | 0.00 | 0.00 | -9.22 | -6.86 | -8.55 | ||
| Changes by years, y/y, % | -212% | -100% | -26% | |||||
Denali Therapeutics. P/FCF
Denali Therapeutics. P/FCF, changes, %
Denali Therapeutics (DNLI) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | -6.06 | -6.52 | -6.09 | -6.86 | -8.55 | -8.55 | ||
| Changes by years, y/y, % | -54% | -28% | +41% | |||||
| Changes by quarters, q/q, % | -36% | +8% | -7% | +13% | +25% | |||
